跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 43 条关于
“H1047R”
全部
43
临床试验
14
药物
19
机构
0
资讯
10
7个月前
OnKure Faces Critical Data Readout for H1047R-Specific PI3Kα Inhibitor as Competition Intensifies
10个月前
Recursion Achieves $500M Partnership Milestone with Novel Microglial Cell Map for Neurological Disease Research
去年
Inavolisib Demonstrates Promising Disease Control in PIK3CA-Mutated Solid Tumors
2年前
Inavolisib Shows Promise in PIK3CA-Mutated Advanced Solid Tumors
上个月
Recursion Pharmaceuticals Advances First AI-Discovered Neuroscience Target with Genentech, Lowers Cash Burn Guidance
去年
OnKure Therapeutics Advances Mutant-Specific PI3Kα Inhibitor OKI-219 Following Merger
去年
FDA Approves Caris Life Sciences' MI Cancer Seek as Companion Diagnostic
去年
FDA Approves Caris Life Sciences' MI Cancer Seek as Companion Diagnostic
去年
Caris Life Sciences' MI Cancer Seek Receives FDA Approval as Companion Diagnostic
去年
FDA Approves MI Cancer Seek as Companion Diagnostic for Targeted Therapy Across Tumor Types